The discovery research center could uncover molecular markers that enable new diagnostics and lead to potential therapies for people living with neurological complications related to HIV.
Financial strategies can advance sustainability goals, but only if environmental trade-offs can be measured and incorporated into decisions, a panel of experts said at a Climate Week NYC 2026 event co-hosted by the SC Johnson College and Cornell Atkinson.
Weill Cornell Medicine investigators have determined the mechanism by which a molecule within cells can help tune the light sensitivity of the eyes, a finding that should enable the development of drugs that target this site to treat related eye diseases.
As an undergraduate researcher, Maya Mangala-Munuma '25 found that trees were three times more likely to be damaged in impoverished, racially diverse neighborhoods.
Chronic stress may contribute to the pain and urinary symptoms experienced by people with interstitial cystitis/bladder pain syndrome by triggering changes in the bladder and nervous system, according to Weill Cornell investigators.
The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells.
Metabotropic glutamate receptors interact in varied ways with their principal regulatory proteins, according to Weill Cornell Medicine investigators. The findings could inform treatments for epilepsy, depression and anxiety disorders.
